Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
2002 1
2003 3
2004 1
2006 2
2007 3
2008 2
2009 2
2010 3
2011 2
2012 2
2013 2
2014 7
2015 6
2016 2
2017 5
2018 9
2019 11
2020 9
2021 15
2022 16
2023 9
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Husain M, et al. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.
Obesity and type 2 diabetes: Also linked in therapeutic options.
Rubio-Almanza M, Cámara-Gómez R, Merino-Torres JF. Rubio-Almanza M, et al. Among authors: merino torres jf. Endocrinol Diabetes Nutr (Engl Ed). 2019 Mar;66(3):140-149. doi: 10.1016/j.endinu.2018.08.003. Epub 2018 Oct 15. Endocrinol Diabetes Nutr (Engl Ed). 2019. PMID: 30337188 Review. English, Spanish.
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Free article. Clinical Trial.
Vitamins and Radioprotective Effect: A Review.
Lledó I, Ibáñez B, Melero A, Montoro A, Merino-Torres JF, San Onofre N, Soriano JM. Lledó I, et al. Among authors: merino torres jf. Antioxidants (Basel). 2023 Mar 1;12(3):611. doi: 10.3390/antiox12030611. Antioxidants (Basel). 2023. PMID: 36978859 Free PMC article. Review.
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.
Bain SC, Mosenzon O, Arechavaleta R, Bogdański P, Comlekci A, Consoli A, Deerochanawong C, Dungan K, Faingold MC, Farkouh ME, Franco DR, Gram J, Guja C, Joshi P, Malek R, Merino-Torres JF, Nauck MA, Pedersen SD, Sheu WH, Silver RJ, Tack CJ, Tandon N, Jeppesen OK, Strange M, Thomsen M, Husain M. Bain SC, et al. Among authors: merino torres jf. Diabetes Obes Metab. 2019 Mar;21(3):499-508. doi: 10.1111/dom.13553. Epub 2018 Nov 11. Diabetes Obes Metab. 2019. PMID: 30284349 Free PMC article. Clinical Trial.
COVID Obesity: A One-Year Narrative Review.
Ovalle DLP, Rodrigo-Cano S, González A, Soler C, Catalá-Gregori AI, Merino-Torres JF, Soriano JM. Ovalle DLP, et al. Among authors: merino torres jf. Nutrients. 2021 Jun 16;13(6):2060. doi: 10.3390/nu13062060. Nutrients. 2021. PMID: 34208529 Free PMC article. Review.
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietilä M, Lincoff AM; SELECT Trial Investigators. Deanfield J, et al. Lancet. 2024 Aug 24;404(10454):773-786. doi: 10.1016/S0140-6736(24)01498-3. Lancet. 2024. PMID: 39181597 Free article. Clinical Trial.
"Five Keys to Safer Food" and COVID-19.
San Onofre N, Soler C, Merino-Torres JF, Soriano JM. San Onofre N, et al. Among authors: merino torres jf. Nutrients. 2021 Dec 15;13(12):4491. doi: 10.3390/nu13124491. Nutrients. 2021. PMID: 34960042 Free PMC article. Review.
Nutritional Assessment in Outpatients with Heart Failure.
López Guillén R, Argente Pla M, Micó García A, Dura de Miguel Á, Gascó Santana E, Martín Sanchis S, Merino Torres JF. López Guillén R, et al. Among authors: merino torres jf. Nutrients. 2024 Aug 26;16(17):2853. doi: 10.3390/nu16172853. Nutrients. 2024. PMID: 39275170 Free PMC article.
106 results